Pulmonology
- DISEASE INDICATIONS: Cystic Fibrosis
- MANUFACTURER: Vertex Pharmaceuticals Incorporated
- USAGE: Oral
- MEDICINE APPROVED BY:
- Food and Drug Administration (FDA)
Trikafta (elexacaftor/tezacaftor/ivacaftor) is a medication used to treat cystic fibrosis in patients aged 12 years and older who have at least one F508del mutation in the CFTR gene.
From $40,150.00
Select optionsThis product has multiple variants. The options may be chosen on the product page